Table of Content



1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations

2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview

3. Market Dynamics
3.1. Key Drivers
3.1.1. Increased Adoption Of Pharmaceutical Continuous Manufacturing Systems
3.1.2. Rising Government Initiatives For The Adoption Of Continuous Manufacturing Systems
3.1.3. Rise In Production Of Large Molecules And Biologics
3.1.4. Increase In Healthcare Expenditure
3.2. Key Restraints
3.2.1. Increasing Customer Anticipations

4. Key Analytics
4.1. Porter’S Five Force Analysis
4.1.1. Threat Of New Entry
4.1.2. Threat Of Substitution
4.1.3. Buyer’S Power
4.1.4. Supplier’S Power
4.1.5. Competitive Rivalry
4.2. Impact Of Covid-19 On Pharmaceutical Continuous Manufacturing Market
4.3. Regulatory Framework
4.4. Opportunity Matrix
4.5. Vendor Landscape
4.6. Key Investment Insights

5. Market By Product
5.1. Integrated Continuous System
5.2. Semi-Continuous System
5.3. Control & Software

6. Market By Application
6.1. Final Drug Product Manufacturing
6.2. Api Manufacturing

7. Market By End-User
7.1. Pharmaceutical Companies
7.2. Contract Manufacturing Organizations
7.3. Other End-Users

8. Geographical Analysis
8.1. North America
8.1.1. Market Size & Estimates
8.1.2. Key Growth Enablers
8.1.3. Key Challenges
8.1.4. Key Players
8.1.5. Country Analysis
8.1.5.1. United States
8.1.5.2. Canada

9. Competitive Landscape
9.1. Key Strategic Developments
9.1.1. Merger & Acquisitions
9.1.2. Product Launch & Developments
9.1.3. Partnership, Contract/Agreement & Collaboration
9.1.4. Business Expansion/ Approval/ Announcement
9.2. Company Profile
9.2.1. Coperion Gmbh
9.2.2. Eli Lilly & Company
9.2.3. Gea Group Ag
9.2.4. Gebruder Lodige Maschinenbau Gmbh
9.2.5. Glatt Gmbh
9.2.6. Hosokawa Micron Corporation
9.2.7. Korsch Ag
9.2.8. Lb Bohle Maschinen + Verfahren Gmbh
9.2.9. Munson Machinery Company
9.2.10. Pfizer Inc
9.2.11. Siemens Healthineers
9.2.12. Syntegon (Formerly Bosch Packaging Technology)
9.2.13. Thermo Fisher Scientific Inc



List of Figures


Figure 1: Porter’S Five Force Analysis
Figure 2: Opportunity Matrix
Figure 3: Vendor Landscape
Figure 4: Key Investment Insights
Figure 5: North America Pharmaceutical Continuous Manufacturing Market, By Product, In 2020
Figure 6: North America Pharmaceutical Continuous Manufacturing Market, By Integrated Continuous System, 2021-2028 (In $ Million)
Figure 7: North America Pharmaceutical Continuous Manufacturing Market, By Semi-Continuous System, 2021-2028 (In $ Million)
Figure 8: North America Pharmaceutical Continuous Manufacturing Market, By Control & Software, 2021-2028 (In $ Million)
Figure 9: North America Pharmaceutical Continuous Manufacturing Market, By Application, In 2020
Figure 10: North America Pharmaceutical Continuous Manufacturing Market, By Final Drug Product Manufacturing, 2021-2028 (In $ Million)
Figure 11: North America Pharmaceutical Continuous Manufacturing Market, By Api Manufacturing, 2021-2028 (In $ Million)
Figure 12: North America Pharmaceutical Continuous Manufacturing Market, By End-User, In 2020
Figure 13: North America Pharmaceutical Continuous Manufacturing Market, By Pharmaceutical Companies, 2021-2028 (In $ Million)
Figure 14: North America Pharmaceutical Continuous Manufacturing Market, By Contract Manufacturing Organizations, 2021-2028 (In $ Million)
Figure 15: North America Pharmaceutical Continuous Manufacturing Market, By Other End-Users, 2021-2028 (In $ Million)
Figure 16: North America Pharmaceutical Continuous Manufacturing Market, Country Outlook, 2020 & 2028 (In %)
Figure 17: United States Pharmaceutical Continuous Manufacturing Market, 2021-2028 (In $ Million)
Figure 18: Canada Pharmaceutical Continuous Manufacturing Market, 2021-2028 (In $ Million)


List of Tables


TABLE 1: MARKET SNAPSHOT - PHARMACEUTICAL CONTINUOUS MANUFACTURING
TABLE 2: NORTH AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 3: NORTH AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 4: NORTH AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 5: NORTH AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 6: NORTH AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 7: NORTH AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY END-USER, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 8: NORTH AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 9: NORTH AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 10: LEADING PLAYERS OPERATING IN NORTH AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET